Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. 1993

S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
Laboratory of Cell Biology, National Cancer Institute, Bethesda, MD 20892.

The product of the p53 gene suppresses cell growth and plays a critical role in suppressing development of human tumors. p53 protein binds DNA, activates transcription, and can be phosphorylated at N- and C-terminal sites. Previously, wild-type p53 was shown to be hyperphosphorylated compared to mutant p53 during p53-mediated growth arrest in vivo. Here we show that Ser-15 and Ser-9 in the N-terminal transactivation domain of wild-type human p53 are phosphorylated in vivo in cells derived from the human glioblastoma line T98G. In [Ile237]p53 and [Ala143]p53, two natural p53 mutants from human tumors that are defective for activation of transcription, phosphorylation at Ser-15 was reduced and phosphorylation at Ser-392 was increased compared to wild-type p53. No change was observed at Ser-9. [His273]p53, a third mutant, had a phosphorylation state similar to that of wild-type p53. We suggest that phosphorylation of Ser-15 may depend on the ability of p53 to adopt a wild-type conformation and may contribute to p53's ability to block cell growth.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010748 Phosphopeptides PEPTIDES that incorporate a phosphate group via PHOSPHORYLATION. Phosphopeptide
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53

Related Publications

S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
November 1994, Oncogene,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
August 1999, Biochemical and biophysical research communications,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
January 2016, Oncotarget,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
June 2009, Biochemical and biophysical research communications,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
July 2004, Molecular cancer therapeutics,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
October 2011, Cancer research,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
October 1992, International journal of oncology,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
November 2009, FEBS letters,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
October 2000, Proceedings of the National Academy of Sciences of the United States of America,
S J Ullrich, and K Sakaguchi, and S P Lees-Miller, and M Fiscella, and W E Mercer, and C W Anderson, and E Appella
May 1995, Cancer letters,
Copied contents to your clipboard!